How is directed evolution changing the competitive landscape for protease producers?

How is directed evolution changing the competitive landscape for protease producers?
Directed evolution, pioneered by Frances Arnold, has transformed protease development. For subtilisin, random mutagenesis via error-prone PCR and iterative screening can improve activity in organic solvents or boost stability under industrial conditions. This means producers can now tailor enzymes for specific applications—detergents that work in cold water, or enzymes that survive bleach—rather than relying on wild-type strains. The technology lowers the barrier for differentiation, enabling Chinese manufacturers to move beyond generic commodity enzymes. However, it also raises R&D costs and requires sophisticated screening infrastructure. Companies that master directed evolution can command premium prices and secure long-term supply contracts. The trend aligns with China's push for synthetic biology and cell factory industrialization, where engineered Bacillus subtilis strains are already used for amino acids and organic acids at commercial scale.